Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes

Effect of Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes:Randomized Clinical Trial

In diabetic individuals, changes in ventilatory muscle strength and lung function have been demonstrated over the years. The onset and progression of chronic complications in diabetes should be avoided by reaching glycated hemoglobin (HbA1c) levels below 7%. The control of glycemia through the measurement of HbA1c is fundamental to avoid complications. The inspiratory muscle training has been used in several clinical situations, and may be an alternative for individuals with type 2 diabetes mellitus who have difficulties performing conventional exercises. The long-term effect of inspiratory muscle training on glycemic control has not been tested yet. The aim of this study is to evaluate the effects of inspiratory muscle training on glycemic control in individuals with type 2 diabetes.

Study Overview

• Status: Unknown
• Conditions: Diabetes Mellitus, Type 2
• Intervention / Treatment: Device: Inspiratory muscle training.; Device: Placebo inspiratory muscle

Detailed Description

An acute high intensity inspiratory muscle exercise session was able to reduce glycemic levels (24%) similarly to an aerobic exercise session (25%) in subjects with type 2 diabetes, demonstrating that this type of exercise inspiratory muscle may have great potential in improving glycemic control.The present study will investigate if training of the inspiratory musculature for 8 and 12 weeks is capable of improving glycated hemoglobin, glucose and inspiratory muscle strength in individuals with type 2 diabetes. In addition, this study will evaluate the effect of inspiratory muscle training, with moderate loading of 30% of the MIP, on volumes and capacities lung in patients with type 2 diabetes. The subjects with type 2 diabetes will be recruited from the ambulatory of the Hospital de Clinicas de Porto Alegre and through newspaper advertisements.

Patients will be submitted to a general evaluation, including clinical history, physical examination, laboratory evaluation and application of the international physical activity questionnaire. Subsequently, individuals will perform assessments of lung functions (lung function assessment, ventilatory muscle strength test, inspiratory muscle strength test) and autonomic assessment (Ewing's tests). Patients will be randomized to perform inspiratory muscle training with a placebo load (MIP 2%) or with moderate intensity (MIP 30%). Upon the randomization, participants will initiate inspiratory musculature training. The exams of HbA1c, glucose and ventilatory muscle strength tests will be performed in three moments: 1) at the initial assessment, 2) in the eighth week of inspiratory muscle training, and 3) at the end of the training (twelfth) week. During inspiratory muscle training, individuals will attend on Hospital de Clinicas de Porto Alegre, once a week, to the supervision of the way the exercise is being performed. Furthermore, it will be set to load on the PowerBreathe ® device for the following week.

• Study Type: Interventional
• Enrollment (Anticipated): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Beatriz D'Agord Schaan, PhD; Phone Number: 55 51993138534; Email: bschaan@hcpa.edu.br
• Study Contact Backup: Name: Mariana Brutto de Pinto; Phone Number: 55 51 981512270; Email: maribpinto@yahoo.com.br

Study Locations

• Brazil
  • Rio grande do sul
    • Porto Alegre, Rio grande do sul, Brazil, 90.035-903
      • Recruiting
      • Hospital de Clinicas de Porto Alegre
      • Contact: Beatriz D'agord Schaan, PhD; Email: bschaan@hcpa.edu.br

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 30 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Type 2 diabetes;
• 30 years and older;
• HbA1c from 7,5 to 10%.

Exclusion Criteria:

• Pregnant women;
• Pulmonary disease (chronic obstructive pulmonary disease, exercise-induced asthma, idiopathic pulmonary fibrosis, sarcoidosis and lung neoplasms);
• Neuromuscular disease;
• Body mass index > 35 kg/m²;
• Individuals who perform physical exercise more than twice a week;
• Current smoking.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Inspiratory muscle training; Patients will perform the inspiratory muscle training using a load moderate of 30% of maximal inspiratory pressure (MIP 30%).	Device: Inspiratory muscle training.; Patients will perform the inspiratory muscle training using a moderate load of 30% of maximal inspiratory pressure (MIP 30%). The training will be conducted at home in a period of 30 minutes, 7 times a week, during 12 weeks. During inspiratory muscle training, individuals will attend Hospital de Clinicas de Porto Alegre once a week to the supervision of the way the exercise is being performed. Furthermore, load in the device (powerbreathe) will be adjusted for the individual to use next week.
Placebo Comparator: Placebo inspiratory muscle; Patients will perform the inspiratory muscle training using a load of 2% of maximal inspiratory pressure (MIP 2%).	Device: Placebo inspiratory muscle; Patients will perform the inspiratory muscle training using a very low load of 2% of maximal inspiratory pressure (MIP 2%). The training will be conducted at home in a period of 30 minutes, 7 times a week, in the course of 12 weeks. During inspiratory muscle training, individuals will attend Hospital de Clinicas de Porto Alegre once a week to the supervision of the way the exercise is being performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Glycated hemoglobin in 8 weeks	Glycated hemoglobin concentration after 8 weeks of inspiratory muscle training	Evaluated in 8 weeks of inspiratory muscle training
Glycated hemoglobin in 12 weeks	Glycated hemoglobin concentration after 12 weeks of inspiratory muscle training	Evaluated in 12 weeks of inspiratory muscle training

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Glucose in 8 weeks	Fasting plasma glucose concentration after 8 weeks of inspiratory muscle training.	Evaluated in 8 weeks of inspiratory muscle training
Glucose in 12 weeks	Fasting plasma glucose concentration after 12 weeks of inspiratory muscle training.	Evaluated in 12 weeks of inspiratory muscle training
Respiratory muscle strength in 8 weeks	Maximum respiratory muscle strength after 8 weeks of inspiratory muscle training, through the measurement of the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP).	Evaluated in 8 weeks of inspiratory muscle training
Respiratory muscle strength in 12 weeks	Maximum respiratory muscle strength after 12 weeks of inspiratory muscle training, through the measurement of the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP).	Evaluated in 12 weeks of inspiratory muscle training
Ventilatory muscle resistance	Muscular endurance ventilatory after 12 weeks of inspiratory muscle training, through analysis of the MIP.	Evaluated in 12 weeks of inspiratory muscle training
Lung functions	Capacity and volumes lung after 12 weeks of inspiratory muscle training.	Evaluated in 12 weeks of inspiratory muscle training

Collaborators and Investigators

• Sponsor: Hospital de Clinicas de Porto Alegre
• Investigators: Principal Investigator: Beatriz D'Agord Schaan, PhD, Hospital de Clinicas de Porto Alegre

Publications and helpful links

General Publications

• Pinto MB, Bock PM, Schein ASO, Portes J, Monteiro RB, Schaan BD. Inspiratory Muscle Training on Glucose Control in Diabetes: A Randomized Clinical Trial. Int J Sport Nutr Exerc Metab. 2021 Jan 1;31(1):21-31. doi: 10.1123/ijsnem.2020-0175. Epub 2020 Nov 27.

Study record dates

Study Major Dates

• Study Start (Actual): July 11, 2017
• Primary Completion (Anticipated): December 31, 2018
• Study Completion (Anticipated): January 31, 2019

Study Registration Dates

• First Submitted: June 15, 2017
• First Submitted That Met QC Criteria: June 15, 2017
• First Posted (Actual): June 19, 2017

Study Record Updates

• Last Update Posted (Actual): August 14, 2017
• Last Update Submitted That Met QC Criteria: August 11, 2017
• Last Verified: August 1, 2017

More Information

Terms related to this study

• Keywords: Exercise; Inspiratory muscle training; Glucose; Glycemic control; Diabetes mellitus, type 2; Diaphragm exercise; Inspiratory loading
• Additional Relevant MeSH Terms: Pathologic Processes; Glucose Metabolism Disorders; Metabolic Diseases; Respiratory Tract Diseases; Respiration Disorders; Endocrine System Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Respiratory Aspiration
• Other Study ID Numbers: 61986916.9.0000.5327

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No